Tiep Le

Tiep Le began their work experience at CTI BioPharma in 1992 as a Research Associate. They then moved on to Immunex in 1996, where they served as a Research Scientist until 2002. Following that, they worked at Amgen as a Research Scientist from 2002 to 2014. In 2015, Tiep joined Ambrx as a Scientist II, managing the vivarium and leading the invivo team for an antibody drug conjugate program. In 2016, they joined Pionyr Immunotherapeutics as a Sr Scientist II, responsible for overseeing in vivo studies and developing rodent disease models. In 2019, Tiep joined Surrozen as a Senior Vivarium Manager, responsible for managing the vivarium facility and leading vivarium operations. Currently, Tiep is the Associate Director and Head of In Vivo Pharmacology at Frontier Medicines starting in 2022.

Tiep Le attended Virginia Commonwealth University from 1980 to 1984, majoring in Biochemistry.